News and Announcements
Analytica’s Pericoach Published in Journal of Urology and Research
- Published September 16, 2016 5:27PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th September 2016, ASX Announcement
Analytica Ltd (ASX: ALT) continues to execute their strategy for demonstrating PerCoach® clinical efficacy with the company’s latest publication in the internationally regarded Journal of Urology and Research.
The case study details the experience of a 70-year old female with Multiple Sclerosis (MS) and faecal incontinence using PeriCoach as an adjunct treatment to her physical therapy sessions. The study is authored by Physical Therapist Dawn Sandalcidi, RCMT, BCB-PMD who sepcialises in orthopaedic manuel therapy and pelvic muscle dysfuntion treatment, and is the owner of Physical Therapy Specialists in Colorado. Ms Sandalcidi is a member of Analytica’s US Clinical Advisory Board.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
